Register
DCGI to fast-track COVID-19 drug, vaccine approval |
Clinical News
eMediNexus Coverage from: 
DCGI to fast-track COVID-19 drug, vaccine approval

0 Read Comments                

Mumbai: The Drugs Controller General of India (DCGI) has stated that it is going to fast-track the approval of all companies which have a drug or vaccine for COVID-19 treatment, in an attempt to accelerate research and development (R&D) that could offer treatment or cure for the disease.

Applications from companies will be given “high priority”, said the DCGI. It further stated that companies will be assisted in speeding up their research… (ET Healthworld, March 23, 2020)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now